AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Merck & Co., Inc. Director's Dealing 2018

Jan 25, 2018

284_dirs_2018-01-24_0481cba7-43e2-4cd1-b2a2-81eb876d1124.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Menlo Therapeutics, Inc. (MNLO)
CIK: 0001566044
Period of Report: 2018-01-24

Reporting Person: Merck & Co., Inc. (10% Owner)
Reporting Person: Merck Sharp & Dohme Corp. (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1243168	Indirect

Footnotes

F1: These securities are owned directly by Merck Sharp & Dohme Corp., which is a direct, wholly owned subsidiary of Merck & Co., Inc. ("Merck"). Merck is an indirect beneficial owner of the reported securities.